Vice President, Canadian Society for Immunology (CSI)
Professor, Departments of Microbiology and Immunology, Medicine, and Surgery
London, ON, Canada
Dr. Mansour Haeryfar obtained his Doctorate in Laboratory Medicine from the National University of Tehran in 1996, his M.Sc. degree from University of Manitoba in 1999, and his Ph.D. from Dalhousie University in 2003. For his postdoctoral studies, Dr. Haeryfar trained with Drs. Jonathan Yewdell and Jack Bennink at National Institutes of Health (NIH) in Bethesda, Maryland, USA. He was then recruited by Western University in 2006 where he currently works as a Full Professor of immunology. He currently serves as the Vice President of the Canadian Society for Immunology (CSI). Dr. Haeryfar investigates mainstream and innate-like T cell responses to microbial pathogens and cancer with the ultimate goal of inventing and optimizing novel T cell-based therapies for human malignancies, infectious diseases and sepsis. He has authored over 90 scientific articles and book chapters, and given many invited lectures at national and international venues. Dr. Haeryfar’s research has earned him numerous prestigious awards, including but not limited to a Fogarty International Fellowship award from NIH, an Ontario Ministry of Research and Innovation (OMRI) Early Researcher Award, a Leaders Opportunity Fund from Canada Foundation for Innovation (CFI), a Tier 2 Canada Research Chair (CRC) award, and an American Association of Immunologists (AAI) Careers in Immunology Fellowship. Dr. Haeryfar’s research programs have been supported by the Canadian Institutes of Health research (CIHR), Natural Sciences and Engineering Research Council of Canada (NSERC), Canadian Cancer Society (CCS), Cancer Research Society Inc., and Prostate Cancer Canada (PCC) among other granting agencies.